Evidence map›Paper›PMID 38745818›Full record

ArticleCureus2024

Lance-Adams Syndrome in the Intensive Care Unit: A Case Report.

Diego Angeles-Sistac, Marta Izura-Gomez, Ainara Barguilla-Arribas, Alba Sierra-Marcos, Indalecio Moran-Chorro

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diego Angeles-SistacCritical Care Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, ESP.
Marta Izura-GomezCritical Care Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, ESP.
Ainara Barguilla-ArribasNeurology, Hospital de la Santa Creu i Sant Pau, Barcelona, ESP.
Alba Sierra-MarcosNeurology, Hospital de la Santa Creu i Sant Pau, Barcelona, ESP.
Indalecio Moran-ChorroCritical Care Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, ESP.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lance-Adams syndrome (LAS), or chronic post-hypoxic myoclonus, is a myoclonic disorder following acute cerebral hypoxia after successful cardiopulmonary resuscitation (CPR). LAS is distinct from acute post-hypoxic myoclonus (acute PHM), presenting with myoclonic jerks and cerebellar ataxia after regaining consciousness. However, the overlap at the onset complicates differentiation and may lead to the withdrawal of life-sustaining measures, especially in sedated ICU patients. The presented case involves a 77-year-old male diagnosed with LAS post-CPR. Despite the presence of early myoclonic jerks EEG, laboratory testing, and neuroimaging showed no definitive proof of irreversible neurological damage. Once diagnosed, treatment involved sequential antiseizure medications and physical therapy when the patient achieved full consciousness. However, the patient ultimately faced severe disabilities and was unable to recover. This case report emphasizes the importance of limiting sedation, comprehensive clinical examination, and the use of complementary tests when no definitive proof of irreversible neurological damage is present after acute cerebral hypoxia. While LAS has a better vital prognosis than acute PHM, it is associated with poor neurofunctional recovery and chronic disability in most cases. Further research is essential for evidence-based management.

Indexed as

acute cerebral hypoxiaacute post-hypoxic myoclonuscardiac arrestcase reportlance-adams syndrome (las)medical intensive care unit (micu)movement disorders and tremorsneurocritical care unitpost-hypoxic myoclonusseizure phenomenology

Identifiers

PMID38745818
PMCPMC11093032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.